Page 140 - Materials Chemistry, Second Edition
P. 140

Biological Approach for Removal of Pharmaceutical Pollutants    121



                                                Raw
                                              materials

                            Technique               Recycle on
                                          Production  site
                                           process
                            Management



                                        Products Wastes
                                                    Recycle/Reuse
                                                     out of the site

           FIGURE 7.1  Wastewater management.


           7.3  ENVIRONMENTAL RISKS OF PHARMACEUTICAL PRODUCTS
           The environmental risk posed by pharmaceutical products in water is of extraordinary
           significance for the health of both people and aquatic organisms. The recognition of
           chemical compounds in any natural network does not necessarily imply that it is of con-
           cern or may cause harm. In any case, real concerns emerge from the location of chemicals
           for which there is confirmation that they may unfavorably influence oceanic life (Ebele
           et al., 2017). Figure 7.2 illustrates the environmental risks of pharmaceutical products.


           7.3.1  bioaccuMulaTion
           Pharmaceutical products are identified in the fresh water environment at moderately
           low concentrations. Many of them and their metabolites are naturally active and can


                                     Environmental risk of
                                   pharmaceutical products





                     Bioaccumlation       Persistence      Toxicity
                       Non-target         Pseudo-          Poly chlorinated
                     aquatic organism     persistent       biphenyls (PCBs)

                     Plant biomass-                        Perfluoroalkyl
                        algae                               substances

                                                           Polybrominated
                                                           diphenyl ethers

           FIGURE 7.2  The environmental risks of pharmaceutical products.
   135   136   137   138   139   140   141   142   143   144   145